IRIS
SPARATORE, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.721
Totale 5.721
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.721
Totale 5.721
Salva come PNG Salva come JPEG
Città #
Genova 4.582
Rapallo 684
Genoa 415
Vado Ligure 31
Bordighera 9
Totale 5.721
Salva come PNG Salva come JPEG
Nome #
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 185
Clofazimine analogs with antileishmanial and antiplasmodial activity 170
Antiviral activity of benzimidazole derivatives. II Antiviral activity of 2-phenylbenzimidazole derivatives. 157
Quinolizidinyl-benzimidazoles as platelet-antiaggregating agents 144
Aromatic Schiff bases and 2,3-disubstituted-1,3-thiazolidin-4one derivatives as anti-inflammatory agents 142
Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives 137
Organometallic compounds in oncology: implications of novel organotins as antitumor agents 134
Gold(I) complexes as antimicrobial agents 132
Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities 132
Acridine derivatives as anti-BVDV agents 131
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 130
Formation of basic compounds during the indole cyclization of ketone phenylhydrazones 128
The Influence of the Nitrogen Substitution in Three Cytisine Derivatives as Ligands for the Neuronal nAChRs: A Structural and Theoretical Study 125
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation 125
Benzimidazole derivatives endowed with potent antileishmanial activity 125
1-(Arylalkyl)quinolizidine derivatives and thio-isosteric analogues as ligands for sigma receptors 121
Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents 118
Spiro[1,2,4-benzotriazine-3(4H),4’-(1’-substituted)-piperidines] and related compounds as ligands for sigma receptors 117
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity 116
N-Homolupinanoyl and N-(ω-lupinylthio)alkanoyl derivatives of some tricyclic systems as ligands for muscarinic M1 and M2 receptor subtypes 116
Synthesis and pharmacological evaluation of some thiolupinine derivatives 115
Antiinflammatory and antinociceptive activities of some benzotriazolylalkanoic acids 112
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation 110
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines 109
Quinolizidine derivatives with antitubercular activity 109
Synthesis, binding, and modeling studies of new cytisine derivatives as ligands for neuronal nicotinic acetylcholine receptor subtypes 108
(+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype 106
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation 106
Epimerization of lupinine to epilupinine and vice versa. Reexamination of the structures of lupinal and epilupinal 104
Triorganotin compounds as antimicrobial agents 102
In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo 102
Antimicrobial and cytotoxic arylazoenamines. Part III: Antiviral activity of selected classes of arylazoenamines 101
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity 101
Antiviral Activity of Benzimidazole Derivatives. I. Antiviral Activity of 1-Substituted-2-[(Benzotriazol-1/2-yl)methyl]benzimidazoles. 99
New arylsparteine derivatives as positive inotropic drugs 99
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease 95
On the self-condensation of aminoguanidine leading to 1,1,4,10,10-pentaamino-2,3,5,6,8,9-hexaazadeca-1,3,5,7,9-pentaene (Structure elucidation through X-ray powder diffraction) 94
Preparation and pharmacological activities of spiro[3,4-dihydro-6/7-R-1,2,4-benzotriazine-3,4'-(1'-substituted)piperidines] 92
Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors 92
Synthesis and biological investigations of 1-(tetrahydropyran-2'-yl)- and 1-(tetrahydrofuran-2'-yl)-benzimidazoles and 1/2-(tetrahydropyran-2'-yl)- and 1/2-(tetrahydro-furan-2'-yl)benzotriazoles 89
Quinolizidine derivatives as ligands for sigma receptors 86
Antitubercular and antiprotozoal activities of quinolizidinyl/pyrrolizidinylalkyliminophenazines 84
Synthesis and preliminary pharmacological evaluation of 3-[2-(1-aryl-piperazin-4-yl)ethyl]-3,4-dihydro-3-methyl-6-R-1,2,4-benzotriazines 81
Synthesis and biological investigation of 2-(tetrahydropyran-2'-yl) and 2-(tetrahydrofuran-2'-yl)-benzimidazoles 76
Synthesis and antiplasmodial activity of novel chloroquine analogues with bulky basic side chains 75
Nuove acquisizioni sulla ciclizzazione di Fischer di arilidrazoni del metil-lupinilchetone 73
Antitumor activity of a new o rally active organotin compound: a preliminare study in murine tumor models 71
Celecoxib, a COX-2 inhibitor, blocks microglial activation induced by a neurotoxic conformer of hPrP90-231 71
Quinolizidinyl derivatives of bi- and tricyclic systems as AChE/BchE and beta-amyloid aggregation inhibitors, 66
Novel organotins as antitumor agents 64
Thiolupinine and some derivatives of pharmacological interest 59
Andamento della ciclizzazione indolica di fenilidrazoni di alchil-(chinolizidin-1'-il)metilchetoni 57
Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-([Formula: see text]-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines. 57
Preparazione e attività farmacologica di ammido-derivati 3-metil-3,4-diidro benzo e pirido-1,2,4-triazin-3-acetici 38
Quinolizidine-derived lucanthone and amitriptyline analogues endowed with potent antileishmanial activity 37
null 35
Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease 23
Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo 6
Further quinolizidine derivatives as antiarrhythmic agents-3 4
Totale 5.793
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.656
article - articoli 15.641
book - libri 0
conference - conferenze 1.015
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.594 0 42 86 126 150 179 258 101 149 265 168 70
2020/2021375 27 35 24 27 22 32 19 35 36 45 36 37
2021/2022782 45 35 68 101 22 38 38 198 12 61 41 123
2022/2023780 64 34 11 70 158 144 3 65 118 3 99 11
2023/2024332 14 51 10 49 17 77 13 20 8 7 30 36
2024/202536 14 22 0 0 0 0 0 0 0 0 0 0
Totale 5.793